<DOC>
	<DOCNO>NCT02370550</DOCNO>
	<brief_summary>The purpose large multicenter , randomize , double-blinded , control clinical study investigate efficacy safety Cyclosporin A primary Sjogren 's syndrome associate pneumonitis ( pSS-IP ) , important implication establishment standardized diagnosis treatment pSS-IP .</brief_summary>
	<brief_title>Cyclosporine A TReatment Interstitial Pneumonitis Associated With Sjogren 's Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Lung Diseases , Interstitial</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>Patients meeting 2002 2012 pSS criterion ; Patients meet diagnostic criterion interstitial pneumonitis ( IP ) ; Patients exertional dyspnea consistent grade 2 Magnitude Task component Mahler Modified Dyspnea Index ; Pulmonary function test : patient percentage force vital capacity ( FVC ) predict values≥45 % , percentage diffuse capacity carbon monoxide ( DLco ) predict values≥30 % , forced expiratory volume one second ( FEV1 ) / FVC &gt; 65 % ; For patient received oral glucocorticoid , dose 10 mg/d ( equivalent amount type glucocorticoid ) ; Patients receive prior treatment immunosuppressant ( include limit CYC , CsA , azathioprine ( AZA ) , tacrolimus ( FK506 ) , methotrexate , leflunomide , etc . ) discontinue therapy least 3 month ; patient receive hydrochloroquine ( HCQ ) , dose stabilize least 3 month ; Patients receive prior treatment biological agent , include limited rituximab , infliximab , adalimumab , etanercept , etc. , discontinue therapy least three month ; For patient prior treatment Nacetylcysteine , dose drug stabilize least 3 month ; The woman reproductive age negative urine pregnancy test . The woman men reproductive age must receive effective contraceptive measure screen period last administration drug ; Patients able read , understand sign inform consent . Patients meet follow criterion participate study . Patients acute exacerbation IP ( AEIP ) ; Arterial blood gas analysis show respiratory failure ; Patients lung disease IP : 1 . Patients severe pulmonary hypertension require specific treatment assess rheumatology immunology expert various clinical center ; 2 . Patients history smoking within last 6 month current smoker ; 3 . Patients serious lung disease , lung tumor active pulmonary infection ; 4 . Lung biopsy , alveolar lavage highresolution computerize tomography ( HRCT ) suggest serious lung disease IP ; Patients rheumatic autoimmune disease , include limited rheumatoid arthritis , systemic lupus erythematosus , inflammatory myopathy , systemic sclerosis , primary biliary cirrhosis , etc . ; Patients serious heart , liver , kidney disease , hematologic and/ endocrine disease : 1 . Heart diseases : decompensated heart failure refractory hypertension ; clinically important abnormal ECG may lead unacceptable risk enrol patient screen ; 2 . Liver function : alanine aminotransferase ( ALT ) and/or aspartate aminotransferase ( AST ) ≥2 time upper limit normal ( ULN ) ; 3 . Renal function : renal tubular and/or interstitial disease , renal insufficiency : serum creatinine≥2 ULN glomerular filtration rate ( eGFR ) &lt; 90 ml/min/1.73 m2 ; 4 . White blood cell ( WBC ) count &lt; 3 ×109/L and/or hemoglobin ( Hb ) &lt; 100 g/L and/or platelet ( PLT ) count &lt; 80×109 /L ; 5 . Other serious disease : cancer , etc . ; Patients active infection disease aggravate treatment glucocorticoid immunosuppressive therapy ; Patients positive HBsAg hepatitis C antibody ; Women pregnancy lactation , guarantee effective contraception ; Patients cooperate treatment mental illness reason ; Patients allergic constitution allergic many drug ; Patients allergic intolerant CsA , CYC , glucocorticoid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>